Acid tolerance and fecal recovery following oral administration of Saccharomyces cerevisiae

Journal of Chemotherapy

Volumn 15, Issue 2, 2003, Pages 143-147

  Scevola, Daniele ^a   Perversi, L ^a   Cavanna, C ^a   Candiani, C ^b   Uberti, F ^a   Castiglioni, B ^a   Marone, P ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Novartis Consumer Health   (Italy)

Author keywords

Acid tolerance; Fecal recovery; Probiotics; Saccharomyces cerevisiae

Indexed keywords

BUFFER; PROBIOTIC AGENT;

ACID TOLERANCE; ACIDITY; ADULT; ARTICLE; BACTERIUM COLONY; CANDIDA; FECES ANALYSIS; FEMALE; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; SACCHAROMYCES CEREVISIAE; TABLET FORMULATION; VOLUNTEER;

EID: 0037951760     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.2.143     Document Type: Article

References (27)

1. Metchnikoff E. The prolongation of life. GP Putnam's Sons; 1908: 161.
2. Fuller R. Probiotics in man and animal. J Appl Bacteriol 1989; 66: 365-378.
3. Elmer GW. Probiotics: "living drugs". Am J Health-Syst Pharm 2001; 58: 1101-1109.
4. Periti P, Tonelli T. Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii. J Chemother 2001; 5: 473-493.
5. Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 2001; 32: 1567-1576.
6. Scevola D, Marone P, eds. Flora intestinale e salute: dalla microbiologia alla clinica. Edizioni Grafiche Mazzucchelli SrL, Milano, 2000.
7. Agarwal N, Kamra DR, Chaudhary LC, Sahoo A, Pathak NN. Selection of Saccharomyces cerevisiae strains for use as a microbial feed additive. Lett Appl Microbiol 2000; 31: 270-273.
8. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections JAMA 1996; 275 (11): 870-876.
9. Lewis SI, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998; 12: 807-822.
10. Saxelin M, Pessi T, Salminen S. Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiology 1995; 25: 199-203.
11. Surawicz CM, Elmer GW, Speelman P, Mc Farland LV, Chinn J, Van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1986; 96: 981-988.
12. Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999; 134: 1-2
13. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271: 1913-1918.
14. Marteau PR, De Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73(suppl): 430S-436S.
15. Bergogne-Bérézin E. Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents 2000; 16: 521-526.
16. Kollaritsch HH, Kemsner P, Wiedermann G, Scheiner O. Prevention of traveller's diarrhoea. Comparison of different non-antibiotic preparations. Travel Med Int 1989: 9-17.
17. Isolauri E, Juntunen M, Rautanen T, et al. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991; 88: 90-97.
18. Guarino A, Canani RB, Spagnuolo MI. Oral bacterial therapy reduces duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 1997; 25: 516-519.
19. Van Niel CW, Feudtner Ch, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109: 678-684.
20. Filho-Lima JVM, Vieira EC, Vicoli JR. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. thyphimurium in gnotobiotic mice. J Appl Microbiol 2000; 88: 365-370.
21. Hochter W, Chase D, Hagenhoff G. Saccharomyces boulardii in acute adult diarrhea. Munch Med Wochenschr 1990; 132: 188-192.
22. Buydens P, Debeuklaere S. Efficacy of SF 68 in the treatment of acute diarrhea: a placebo controlled trial. Scand J Gastroenterol 1996; 31: 887-891.
23. Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yoghurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992; 116: 353-357.
24. Hilton E, Rindos P, Isenberg HD. Lactobacillus GG vaginal suppositories and vaginitis. J Clin Microbiol 1995; 33: 1433.
25. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995; 23: 32-45.
26. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and Lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 1992; 14: 11-16.
27. Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol 2000; 95 (Suppl): S2-S4.